These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17906935)

  • 1. Increased cancer risk for individuals with a family history of prostate cancer, colorectal cancer, and melanoma and their associated screening recommendations and practices.
    Noe M; Schroy P; Demierre MF; Babayan R; Geller AC
    Cancer Causes Control; 2008 Feb; 19(1):1-12. PubMed ID: 17906935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family history of cancer and utilization of prostate, colorectal and skin cancer screening tests in U.S. men.
    Shah M; Zhu K; Palmer RC; Wu H
    Prev Med; 2007 May; 44(5):459-64. PubMed ID: 17320159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
    Leu M; Reilly M; Czene K
    J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of family history of prostate cancer to perceived vulnerability and screening behavior.
    Jacobsen PB; Lamonde LA; Honour M; Kash K; Hudson PB; Pow-Sang J
    Psychooncology; 2004 Feb; 13(2):80-5. PubMed ID: 14872526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening participation in individuals with a family history of colorectal cancer: a review.
    Rees G; Martin PR; Macrae FA
    Eur J Cancer Care (Engl); 2008 May; 17(3):221-32. PubMed ID: 18419625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial risk and colorectal cancer screening health beliefs and attitudes in an insured population.
    Palmer RC; Emmons KM; Fletcher RH; Lobb R; Miroshnik I; Kemp JA; Bauer M
    Prev Med; 2007 Nov; 45(5):336-41. PubMed ID: 17804048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer: screening and surveillance for high-risk individuals.
    Ferrández A; DiSario JA
    Expert Rev Anticancer Ther; 2003 Dec; 3(6):851-62. PubMed ID: 14686707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening men for prostate cancer and colorectal cancer: is practice evidence-based?
    Chun FK; Suardi N; Perrotte P; Lebeau T; Guay JP; Benayoun S; Ramirez A; Bénard F; McCormack M; Valiquette L; Karakiewicz P
    Can J Urol; 2007 Dec; 14(6):3727-33. PubMed ID: 18163923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma early detection.
    Terushkin V; Halpern AC
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):481-500, viii. PubMed ID: 19464598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of screening in melanoma.
    Stratigos AJ; Katsambas AD
    Clin Dermatol; 2009; 27(1):10-25. PubMed ID: 19095150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Opportunistic cancer screening in primary health care. A person out of 13 has symptoms and three out of 1,000 have a tumor].
    Karlsson L; Håkansson A; Nordenskiöld B
    Lakartidningen; 2002 Jun; 99(23):2636-8. PubMed ID: 12101617
    [No Abstract]   [Full Text] [Related]  

  • 12. Employee response to a company-sponsored program of colorectal and prostate cancer screening.
    Myers RE; Vernon SW; Carpenter AV; Balshem AM; Lewis PG; Wolf TA; Hilbert J; DeFonso LR; Ross EA
    Cancer Detect Prev; 1997; 21(4):380-9. PubMed ID: 9232330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Colorectal cancer: a risk-adapted screening and the role of the physician in the prevention of this cancer].
    Chappuis PO; Hutter P
    Rev Med Suisse; 2006 May; 2(66):1314, 1316, 1318-23. PubMed ID: 16775992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma/skin cancer screening in a Mediterranean country: results of the Euromelanoma Screening Day Campaign in Greece.
    Stratigos A; Nikolaou V; Kedicoglou S; Antoniou C; Stefanaki I; Haidemenos G; Katsambas AD
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):56-62. PubMed ID: 17207168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Communication about family members' risk of melanoma: self-reported practices of dermatologists in the United States.
    Oliveria SA; Heneghan MK; Halpern AC; Hay JL; Geller AC
    Arch Dermatol; 2012 May; 148(5):621-7. PubMed ID: 22250188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of genetic and environmental components in colorectal and lung cancer and melanoma.
    Hemminki K; Lönnstedt I; Vaittinen P; Lichtenstein P
    Genet Epidemiol; 2001 Jan; 20(1):107-116. PubMed ID: 11119300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy and completeness in reporting family history of prostate cancer by unaffected men.
    Gaff CL; Aragona C; MacInnis RJ; Cowan R; Payne C; Giles GG; Lindeman GJ
    Urology; 2004 Jun; 63(6):1111-6. PubMed ID: 15183962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the usefulness of self-reported risk factors in a skin cancer screening program.
    Williams HA; Fritschi L; Beauchamp C; Katris P
    Melanoma Res; 2006 Aug; 16(4):341-5. PubMed ID: 16845330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbid illness and the early detection of cancer.
    Gonzalez EC; Ferrante JM; Van Durme DJ; Pal N; Roetzheim RG
    South Med J; 2001 Sep; 94(9):913-20. PubMed ID: 11592754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey.
    Dimitrakaki C; Boulamatsis D; Mariolis A; Kontodimopoulos N; Niakas D; Tountas Y
    Eur J Cancer Prev; 2009 Jun; 18(3):248-57. PubMed ID: 19491613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.